Intrinsic Value of S&P & Nasdaq Contact Us

Unicycive Therapeutics, Inc. UNCY NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
46/100
1/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Stock Statistics — UNCY

Unicycive Therapeutics, Inc. (UNCY) has a market capitalization of $149.15M and trades at $6.94. The 52-week range is 3.71-11.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -4.2, Earnings Per Share (EPS) of $-1.67.

The stock has a beta of 1.80, operates in the Healthcare sector.

Trading Data
Current Price$6.94
52-Week Range3.71-11
Volume635.55K
Avg Volume (30D)648.41K
Market Cap$149.15M
Beta (1Y)1.80
Company
IPO Date2021-07-12
Employees22
CEOShalabh K. Gupta
CountryUS
ExchangeNASDAQ Capital Marke
CurrencyUSD
ISINUS90466Y2028
CUSIP90466Y202
Income (Latest Year)
EBITDA$-25.91M
Operating Income$-29.52M
Net Income$-26.56M
EPS$-1.67
EPS Diluted$-1.67
Shares Outstanding$158.87M
Balance Sheet (Latest Year)
Total Assets$49.14M
Current Assets$48.96M
Cash & ST Investments$41.27M
Total Liabilities$18.94M
Total Debt$117K
Net Debt$-29.08M
Total Equity$30.2M
Debt / Equity0.00
Valuation Ratios
P/E Ratio-4.2
P/B Ratio4.94
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message